A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine

We examined the safety, immunogenicity and efficacy of a prime-boost vaccination regime involving two poxvirus malaria subunit vaccines, FP9-PP and MVA-PP, expressing the same polyprotein consisting of six pre-erythrocytic antigens from Plasmodium falciparum. Following safety assessment of single do...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Porter, David W., Thompson, Fiona M., Berthoud, Tamara K., Hutchings, Claire L., Andrews, Laura, Biswas, Sumi, Poulton, Ian, Prieur, Eric, Correa, Simon, Rowland, Rosalind, Lang, Trudie, Williams, Jackie, Gilbert, Sarah C., Sinden, Robert E., Todryk, Stephen, Hill, Adrian V.S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier Science 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3195259/
https://ncbi.nlm.nih.gov/pubmed/21501642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2011.03.083
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak